跳至主要内容
临床试验/NCT05979142
NCT05979142已完成不适用

A Prospective Cohort Study of a Community-based Primary Care Program's Effects on Pharmacotherapy Quality in Low-income Peruvians With Type 2 Diabetes and Hypertension

Asociación Siempre Salud0 个研究点目标入组 131 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
131
主要终点
Hypoglycemic agent standard

研究概览

简要总结

The goal of this observational study is to compare usual care to a community-based primary care program (having components of treatment decisions based on clinical guidelines, self-management education, community health workers, and free health care visits and medications) in low-income Peruvians with type 2 diabetes and/or hypertension.

The main question[s] it aims to answer are:

  • Compared to pre-program usual care, does the program result in greater benefits, measured as greater proportions of patients with glucose and blood pressure control or maximal quantities and doses of medications?
  • Are there greater benefits when the program was provided at home compared to when the program was provided in a clinic?
  • Does longer participation in the program result in greater benefits?

Participants will participate in:

  • Self-management education provided by community health workers.
  • Monitoring of healthy behaviors and glucose, blood pressure, and weight.
  • Receipt of free medications for blood pressure, glucose, and heart disease prevention.

详细描述

A pre-post study of visit-level data gathered prospectively during a community-based primary care program evaluated its effects on pharmacotherapy of type 2 diabetes and hypertension. The program was conducted by Asociación Siempre Salud, a Peruvian non-profit organization, in three neighborhoods ("the community") in Pueblo Nuevo, Chincha District, Peru. Door-to-door surveys identified all persons residing in the study community. Persons > 35 years old were eligible, without exclusions, to participate in type 2 diabetes and hypertension screening and diagnosis. Most participated in mass screenings between September and December 2011, others in later ad hoc screenings. Patients with negative screening results on medications were re-screened following medication withdrawal. Those with confirmed diagnoses were eligible to participate in the program.

Three binary exposures were evaluated for their effects on adherence to four treatment standards and one composite standard: 1) 'program exposure' (post- vs. pre-exposure); 2) 'program retention in care' (>50% of allowable time in both home and clinic care periods, compared to <50% in either care period (but not both)), and 3) 'care period', (clinic compared to home care). 'Care period treatment time' (>50% of allowable time versus less) was evaluated as an independent variable in the study of the care period exposure.

During the pre-exposure period, usual care was provided by two public hospitals, several Ministry of Health clinics, private clinics and pharmacies, and Siempre Salud. The program, to which patients were then exposed, had components of four CCM elements (delivery system design, self-management, decision support, and community resources), CHWs, and no out-of-pocket costs for visits and medications. Self-management was based on national standards and utilized educational materials from professional societies and government agencies in the USA. Decision support consisted of guidelines-based standards adapted to our low-resource setting and simplified medication treatment protocols for diabetes, hypertension, and primary prevention of CVD. The delivery system consisted of two care models employed sequentially: first home care, then clinic care (see care period exposure).

During the home care period, the physician made an initial visit, after which CHWs made weekly visits to patients' homes. CHWs monitored clinical parameters, provided self-management education and support, tracked self-care behaviors, documented visits, acted on clinical alerts, and delivered medications. They entered encounter data into a spreadsheet and filled prescriptions under physician supervision. The physician made treatment decisions reliant on home visit data and patient care conferences. During the subsequent clinic period, patients made monthly visits to the clinic physician who provided all care.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 35 years or older with confirmed diagnosis of type 2 diabetes and/or hypertension

排除标准

  • 未提供

结局指标

主要结局

Hypoglycemic agent standard

时间窗: 27 months

Standard was defined as glycemic control or maximum doses of two hypoglycemic agents (metformin and glibenclamide) in eligible patients with type 2 diabetes.

Antihypertensive agent standard

时间窗: 27 months

Standard was defined blood pressure control or maximum doses of three or more antihypertensive agents in eligible patients with elevated blood pressure (\>130/80 mm Hg in diabetics, \>140/90 mm Hg in non-diabetics)

Angiotensin-converting enzyme inhibitor (ACEi) standard

时间窗: 27 months

Standard was defined as any ACEi in eligible patients with diabetes and elevated BP (\>130/80 mm Hg).

Low-dose aspirin standard

时间窗: 27 months

Standard was defined as any low-dose aspirin in eligible patients with 10-year cardiovascular disease (CVD) risk \>10%.

Composite standard

时间窗: 27 months

Coded 'yes' if all treatment standards for which eligible were achieved.

次要结局

未报告次要终点

研究者

发起方
Asociación Siempre Salud
申办方类型
Other
责任方
Sponsor

相似试验